Studies have found that sEVs released by third-generation BMSCs can induce the expression of ACE2 in the plasma of rats with MI, thereby accelerating the conversion of Angiotensin II to Angiotensin 1–7, reducing collagen deposition in the myocardium, and improving cardiac function in rats [360]. The gene discussed is AGT; the disease is myocardial infarction.